SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,006,250 | -45.6% | 36,498 | -40.7% | 0.01% | -46.7% |
| Q2 2023 | $1,851,035 | -10.7% | 61,578 | +7.6% | 0.02% | -16.7% |
| Q1 2023 | $2,073,733 | +100371.6% | 57,238 | -1.1% | 0.02% | +5.9% |
| Q4 2022 | $2,064 | -99.9% | 57,854 | +18.7% | 0.02% | 0.0% |
| Q3 2022 | $1,650,000 | +17.2% | 48,740 | +0.1% | 0.02% | +13.3% |
| Q2 2022 | $1,408,000 | -5.0% | 48,691 | +6.2% | 0.02% | 0.0% |
| Q1 2022 | $1,482,000 | +26.5% | 45,847 | +14.1% | 0.02% | +25.0% |
| Q4 2021 | $1,172,000 | +9.0% | 40,194 | -0.3% | 0.01% | -7.7% |
| Q3 2021 | $1,075,000 | -14.2% | 40,296 | -1.0% | 0.01% | -7.1% |
| Q2 2021 | $1,253,000 | +17.2% | 40,688 | -0.3% | 0.01% | +7.7% |
| Q1 2021 | $1,069,000 | +4.1% | 40,814 | +0.0% | 0.01% | -13.3% |
| Q4 2020 | $1,027,000 | +20.5% | 40,813 | -0.1% | 0.02% | -11.8% |
| Q3 2020 | $852,000 | +35.7% | 40,866 | +54.5% | 0.02% | +41.7% |
| Q2 2020 | $628,000 | +32.2% | 26,447 | +0.2% | 0.01% | +9.1% |
| Q1 2020 | $475,000 | +12.6% | 26,396 | +48.4% | 0.01% | +57.1% |
| Q4 2019 | $422,000 | -13.7% | 17,786 | -0.0% | 0.01% | -22.2% |
| Q3 2019 | $489,000 | -17.7% | 17,790 | -0.8% | 0.01% | -10.0% |
| Q2 2019 | $594,000 | -5.6% | 17,941 | -0.1% | 0.01% | -9.1% |
| Q1 2019 | $629,000 | +5.7% | 17,957 | +0.2% | 0.01% | -8.3% |
| Q4 2018 | $595,000 | -5.3% | 17,919 | +43.8% | 0.01% | +33.3% |
| Q3 2018 | $628,000 | -4.3% | 12,465 | +13.8% | 0.01% | 0.0% |
| Q2 2018 | $656,000 | +196.8% | 10,956 | +127.3% | 0.01% | +200.0% |
| Q1 2018 | $221,000 | – | 4,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |